Cipla Limited

Cipla Limited is an Indian pharmaceutical company founded in 1935 by Khwaja Abdul Hamied as the Chemical, Industrial & Pharmaceutical Laboratories. Cipla makes drugs to treat respiratory, cardiovascular disease, arthritis, diabetes, weight control and depression. It has over 30,000 employees and operates in over 170 countries. Cipla’s product portfolio includes over 1,500 molecules across various therapeutic segments. Cipla has a strong presence in emerging markets with over 60% of its revenues coming from these markets. The company has a diversified product portfolio and a large number of manufacturing facilities. Cipla is a vertically integrated company with a large R&D team. The company has a strong focus on new product development and has launched over 100 new products in the last 5 years. Cipla has a strong marketing and distribution network in India and has a growing presence in developed markets. The company is aiming to become a global top 10 pharmaceutical company by 2020. Cipla’s website is www.cipla.com.